Advances in corneal regenerative medicine with iPS cells

Keyphrases

• Allogeneic 14%
• Anterior Chamber 14%
• Bullous Keratopathy 28%
• Cell Suspension 28%
• Cell Transplant 14%
• Cell-derived 28%
• Cornea 14%
• Corneal Endothelial Cells 57%
• Corneal Endothelium 28%
• Corneal Epithelial 57%
• Corneal Epithelial Cell Sheet 14%
• Corneal Epithelium 14%
• Corneal Stromal Stem Cells 14%
• Cultured Corneal Endothelial Cells 28%
• Donor Cornea 14%
• Epithelial Cell Sheet 57%
• First-in-human 14%
• First-in-human Study 14%
• Induced Pluripotent Stem Cells (iPSCs) 100%
• Japan 28%
• Lancet 14%
• Oral mucosal Epithelia 14%
• Regenerative Medicine 100%
• Regenerative Medicine Products 14%
• ROCK Inhibitor 14%
• Stem Cell Deficiency 14%
• Stem Cell-derived 42%
• Stem Cells 14%

Medicine and Dentistry

• Anterior Chamber of Eyeball 14%
• Bullous Keratopathy 28%
• Clinical Study 42%
• Corneal Endothelium 28%
• Corneal Epithelium 14%
• Endothelial Cell 57%
• Epithelial Cell 14%
• Human Study 14%
• Induced Pluripotent Stem Cell 42%
• Medicine 100%
• Rho Kinase Inhibitor 14%
• Stem Cell 28%
• Transplantation 85%